Year: 2025
Type: dissertation
Abstract: Antimicrobial resistance poses a serious global health threat, creating an urgent need for alternative therapeutic strategies. One promising approach is repurposing non-antibiotic drugs as antimicrobial agents or adjuncts to existing antimicrobial agents. Metformin, a widely used antidiabetic drug, has recently demonstrated antibacterial activity against various bacterial species. However, its mechanism of action and the bacterial response to metformin remain unclear and sometimes contradictory. This thesis investigates the antibacterial effects of metformin, its underlying molecular mechanisms, and how bacteria may adapt to its presence, especially relevant for diabetic patients with long-term exposure. In this thesis, metformin’s effects on bacterial growth, virulence factors, and efflux pump activity across multiple clinically relevant species were investigated. To gain mechanistic insight, transcriptomic profiling using RNA-seq was conducted, and TraDIS was used to identify essential genes under metformin stress. Additionally, combinations with mitochondrial inhibitors and different antibiotic classes were tested to assess synergistic or antagonistic interactions. In addition, an evolutionary experiment with continuous low-dose metformin exposure was performed to track phenotypic and genotypic changes. Metformin was found to exert strain-specific antibacterial effects, disrupting bacterial metabolism, redox balance, and proton motive force. It may also mimic natural polyamines, interfering with enzymatic functions. These disruptions can enhance or reduce antibiotic efficacy depending on the strain and drug class. Importantly, although prolonged exposure did not lead to resistant strains, it suggested that it might encourage the formation of persistent-like cells through energy depletion, which could contribute to chronic infections. These findings underscore the potential and limitations of metformin as an adjunct antimicrobial, highlighting the need for careful consideration in clinical applications involving diabetic patients.
Institution: University of East Anglia
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: metformin, antibacterial activity, drug repurposing, antimicrobial resistance, bacterial virulence factors, efflux pumps, bacterial transcriptomics, mitochondrial inhibitors, antibiotic synergy, antibiotic antagonism, persistent bacteria, chronic infection, diabetic patients, redox homeostasis, proton motive force, bacterial metabolism
Open Access status: green
OpenAlex ID: W7161097433
